99mtc demotate 1: biodistribution and elimination characteristics in rats

Nuclear Medicine Communications

Volumn 26, Issue 6, 2005, Pages 549-554

  Kopecky, Martin ^a   Trejtnar, Frantisek ^b   Laznicek, Milan ^b   Laznickova, Alice ^b   Semecky, Vladimir ^b   Maina, Theodosia ^b   Nock, Berthold ^b  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Biodistribution; Elimination; Renal handling

Indexed keywords

CYCLOPEPTIDE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR; TECHNETIUM COMPLEX; TECHNETIUM TC 99M DEMOTATE; DEMOTATE 1 TC 99M; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; KIDNEY; LIVER; MALE; METABOLIC CLEARANCE RATE; METABOLISM; RAT; SCINTISCANNING; TISSUE DISTRIBUTION; WISTAR RAT; ADRENAL GLAND; ANIMAL EXPERIMENT; AUTORADIOGRAPHY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE; ISOTOPE LABELING; KIDNEY CORTEX; KIDNEY PERFUSION; LIVER PERFUSION; NONHUMAN; PANCREAS; RAT STRAIN; RECEPTOR DENSITY; STOMACH; TUMOR DIAGNOSIS; URINARY EXCRETION;

ANIMALS; KIDNEY; LIVER; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES, CYCLIC; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION;

EID: 20144361949     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200506000-00011     Document Type: Article

References (20)

1. Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992; 33:652-658.
2. 111In-DTPA-octreotide. Peptide Res 1996; 9:144-150.
3. Maina T, Stolz B, Albert R, Bruns C, Koch P, Macke H. Synthesis, radiochemistry and biological evaluation of a new somatostatin analogue (SDZ 219-387) labelled with technetium-99m. Eur J Nucl Med 1994; 21:437-444.
4. 1]octreotide, a new octreotide derivative with high affinity for somatostatin receptors. In: Nicolini M, Banoli G, Mazzi U (editors): Technetium and Rhenium in Chemistry and Nuclear Medicine, 4. Padova: SG Editoriali; 1995, pp. 395-400.
5. 111In-octreotide. J Nucl Med 2000; 41:1114-1119.
6. 111In-pentetreotide scintigraphy. J Nucl Med 2002; 43:889-895.
7. 111In-DTPA-D-Phe1-octreotide. Eur J Nucl Med 2000; 27:628-637.
8. 3]octreotate analogue for the detection of somatostatin receptor-positive tumours: synthesis and preclinical results. Eur J Nucl Med Mol Imaging 2002; 29:742-753.
9. 99mTc-Demotate 1: first data in tumour patients - results of a pilot/phase I study. Eur J Nucl Med Mol Imaging 2003; 30:1211-1219.
10. 99mTc-labeled peptides. J Nucl Med 2000; 41:177-182.
11. Laznickova A, Laznicek M, Kvetina J, Drobnik J. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats. Cancer Chemother Pharmacol 1986; 17:133-136.
12. 3]octreotide: an intrapatient comparison of two novel technetium-99m labeled tracers for somatostatin receptor scintigraphy. Cancer Biother Radiopharm 2004; 19:73-79.
13. 99mTc: Preparation and pharmacokinetics in rats. Sci Pharm 2001; 69:112-113.
14. Laznicek M, Laznickova A, Macke HR, Eisenwiener K, Reubi JC, Wenger S. Octreotide and octreotate derivatives radiolabeled with yttrium: pharmacokinetics in rats. Cancer Biother Radiopharm 2002; 17:527-533.
15. 1-octreotide in rats. Eur J Drug Metab Pharmacokinet 2002; 27:37-43.
16. Duncan JR, Stephenson MT, Wu HP, Anderson CJ. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes. Cancer Res 1997; 57:659-671.
17. Reubi JC, Horisberger U, Studer UE, Waser B, Laissue JA. Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. J Clin Endocrinol Metab 1993; 77:1323-1328.
18. 3-octreotide in the rat kidneys. Nucl Med Biol 2004; 31:231-239.
19. Szilagyi A, Shrier I. Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther 2001; 15:1889-1897.
20. Yavuz MN, Yavuz AA, Aydin F, Can G, Kavgaci H. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study. Int J Radiat Oncol Biol Phys 2002; 54:195-202.